background


Damae Medical Celebrates Milestone: 1st Patient Enrolled in Landmark French Health-Economic Study







April 2024

The launch of the ECOBASO Study is just the start to proving how deepLive™ can change the health-economics of BCC management


April 2024 
Image
The first French randomized trial designed to evaluate the health-economic impact of deepLive™ diagnosis on BCC management compared to traditional invasive biopsy procedures begins with the first patient enrollment in the ECOBASO study.

Read all about it:

Press release in English

Press release in French

Press kit